Waldo Ortuzar
Impact in
- Oncology top 5%
- Metal complexes synthesis and properties
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
-
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 7
- Cancer Immunotherapy and Biomarkers 4
- CAR-T cell therapy research 3
- Metal complexes synthesis and properties 2
- Lung Cancer Research Studies 1
-
- Lung Cancer Treatments and Mutations 2
- Co-authors
- Tito Fojo (2 shared papers)Olivier Rixe (1 shared paper)R. R. Parker (1 shared paper)K Paull (1 shared paper)Manuel Álvarez (1 shared paper)Eddie Reed (1 shared paper)Ralph Zinner (2 shared papers)John N. Weinstein (1 shared paper)
- Journals
- Annals of Oncology (3 papers)Clinical Lung Cancer (2 papers)Biochemical Pharmacology (1 paper)Critical Reviews in Oncology/Hematology (1 paper)Journal of Thoracic Oncology (1 paper)
- Partner nations
- United StatesItalyChile
In The Last Decade
Waldo Ortuzar
10 papers receiving 742 citations
Waldo Ortuzar's Hit Papers
Peers
Comparison fields: 5 of 68
- Oncology 462
- Pulmonary and Respiratory Medicine 135
- Cancer Research 53
- Pathology and Forensic Medicine 61
- Organic Chemistry 109
Countries citing papers authored by Waldo Ortuzar
This map shows the geographic impact of Waldo Ortuzar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Waldo Ortuzar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Waldo Ortuzar more than expected).
Fields of papers citing papers by Waldo Ortuzar
This network shows the impact of papers produced by Waldo Ortuzar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Waldo Ortuzar. The network helps show where Waldo Ortuzar may publish in the future.
Co-authors
The 25 scholars most cited alongside Waldo Ortuzar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panel Hit paper breakdown → | 1996 | 512 |
| 2 | 2014 | 122 | |
| 3 | 2004 | 44 | |
| 4 | 2008 | 32 | |
| 5 | 2011 | 24 | |
| 6 | 2010 | 13 | |
| 7 | 2018 | 6 | |
| 8 | 2018 | 3 | |
| 9 | 2018 | 2 | |
| 10 | 2020 | 2 |
About Waldo Ortuzar
Waldo Ortuzar is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Organic Chemistry and Surgery, having authored 10 papers that have together received 760 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), CAR-T cell therapy research (3 papers), Lung Cancer Treatments and Mutations (2 papers), Metal complexes synthesis and properties (2 papers), Click Chemistry and Applications (1 paper), Lung Cancer Research Studies (1 paper), Cancer Genomics and Diagnostics (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Oncology (462 citations), Pulmonary and Respiratory Medicine (135 citations), Cancer Research (53 citations), Pathology and Forensic Medicine (61 citations) and Organic Chemistry (109 citations). Waldo Ortuzar has collaborated with scholars based in United States, Italy and Chile. Frequent co-authors include Tito Fojo, Olivier Rixe, R. R. Parker, K Paull, Manuel Álvarez, Eddie Reed, Ralph Zinner, John N. Weinstein, Timothy G. Myers and Hideyuki Tanimura. Their work appears in journals such as Annals of Oncology, Clinical Lung Cancer, Biochemical Pharmacology, Critical Reviews in Oncology/Hematology and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.